Paola Allavena

Q: What Schools Are Affiliated With Paola Allavena

Paola Allavena is affiliated with the following schools: University of California, Berkeley, University of Milan, Stanford University, University of Brescia, Humanitas University

Paola Allavena's AcademicInfluence.com Rankings

Paola Allavena

Engineering

#2840

World Rank

#3828

Historical Rank

Biomedical Engineering

#96

World Rank

#97

Historical Rank

Applied Physics

#417

World Rank

#434

Historical Rank

engineering Degrees

Paola Allavena

Biology

#5434

World Rank

#7912

Historical Rank

Immunology

#257

World Rank

#267

Historical Rank

biology Degrees

Download Badge

Engineering
Biology

Why Is Paola Allavena Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paola Allavena's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cancer-related inflammation (2008) (9454)
The chemokine system in diverse forms of macrophage activation and polarization. (2004) (5622)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. (2002) (4728)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. (2009) (2522)
Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s (1998) (2236)
Tumour-associated macrophages as treatment targets in oncology (2017) (2134)
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. (2006) (1396)
Macrophage polarization in tumour progression. (2008) (1113)
Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation (2009) (1096)
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. (2008) (909)
Role of tumor-associated macrophages in tumor progression and invasion (2006) (833)
Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells (2005) (833)
Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells1 (2000) (816)
Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. (1998) (737)
Role of macrophage targeting in the antitumor activity of trabectedin. (2013) (682)
Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells1 (2000) (630)
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. (2005) (608)
The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance (2008) (586)
Cancer related inflammation: the macrophage connection. (2008) (548)
IL‐10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages (1998) (539)
Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells (1997) (498)
The interaction of anticancer therapies with tumor-associated macrophages (2015) (486)
Glucocorticoids affect human dendritic cell differentiation and maturation. (1999) (485)
Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. (1997) (434)
Tumor-associated macrophages: functional diversity, clinical significance, and open questions (2013) (427)
Macrophage polarization in pathology (2015) (425)
Pathways connecting inflammation and cancer. (2008) (399)
Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program 1 (2003) (372)
Immunology in the clinic review series; focus on cancer: tumour‐associated macrophages: undisputed stars of the inflammatory tumour microenvironment (2012) (372)
The chemokine system in cancer biology and therapy. (2010) (364)
Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. (1995) (363)
Tumor-Conditioned Macrophages Secrete Migration-Stimulating Factor: A New Marker for M2-Polarization, Influencing Tumor Cell Motility (2010) (346)
Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. (2001) (343)
Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. (2009) (343)
Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4 (2004) (341)
Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. (2004) (330)
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. (2005) (328)
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. (2001) (325)
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. (1995) (317)
Cytokines as a key component of cancer-related inflammation. (2008) (312)
Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3 (1994) (309)
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer (2011) (296)
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. (2002) (287)
Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys (2000) (277)
Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production. (2005) (275)
Dendritic cells as a major source of macrophage‐derived chemokine/CCL22 in vitro and in vivo (2001) (272)
Cellular and molecular pathways linking inflammation and cancer. (2009) (258)
Tumor-Associated Macrophages (TAM) as Major Players of the Cancer-Related Inflammation (2010) (257)
Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells. (2010) (253)
The role of chemokines in the regulation of dendritic cell trafficking (1999) (248)
Chemokine Receptor Expression and Function in CD4+ T Lymphocytes with Regulatory Activity1 (2001) (244)
Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. (1998) (234)
Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers (2014) (228)
CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study. (2009) (227)
Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma* (2002) (219)
Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. (2010) (217)
Human large granular lymphocytes are potent producers of interleukin-1 (1984) (213)
Chemokines in cancer related inflammation. (2011) (211)
Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. (2004) (208)
The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. (2003) (207)
The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues (2000) (197)
Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. (1987) (193)
Chemokines and Dendritic Cell Traffic (2000) (191)
Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells (1999) (182)
Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer (2007) (182)
The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. (1998) (181)
Inflammation-mediated promotion of invasion and metastasis (2010) (181)
Rapamycin impairs antigen uptake of human dendritic cells1 (2003) (180)
Molecular pathways and targets in cancer-related inflammation (2010) (180)
Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy (2015) (177)
Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells (2003) (175)
Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium (1991) (170)
Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. (2005) (167)
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment (2014) (164)
Molecular pathways in cancer-related inflammation. (2011) (160)
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma. (2008) (158)
Adhesion, transendothelial migration, and reverse transmigration of in vitro cultured dendritic cells. (1998) (155)
Truncation of Macrophage-derived Chemokine by CD26/ Dipeptidyl-Peptidase IV beyond Its Predicted Cleavage Site Affects Chemotactic Activity and CC Chemokine Receptor 4 Interaction* (1999) (155)
Inflammation and cancer: breast cancer as a prototype. (2007) (154)
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses (2019) (153)
From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. (2004) (149)
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma (2016) (145)
Defective Expression of the Monocyte Chemotactic Protein-1 Receptor CCR2 in Macrophages Associated with Human Ovarian Carcinoma1 (2000) (142)
Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells. (2000) (140)
Engagement of the Mannose Receptor by Tumoral Mucins Activates an Immune Suppressive Phenotype in Human Tumor-Associated Macrophages (2011) (140)
Induction of Functional IL-8 Receptors by IL-4 and IL-13 in Human Monocytes1 (2000) (138)
Neutrophils produce biologically active macrophage inflammatory protein‐3α (MIP‐3α) / CCL20 and MIP‐3β / CCL19 (2001) (134)
IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. (1995) (125)
Interleukin-17–Producing T-Helper Cells as New Potential Player Mediating Graft-Versus-Host Disease in Patients Undergoing Allogeneic Stem-Cell Transplantation (2009) (124)
Tumor-Derived MUC1 Mucins Interact with Differentiating Monocytes and Induce IL-10highIL-12low Regulatory Dendritic Cell1 (2004) (119)
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery (2016) (119)
IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences. (1997) (110)
Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. (1997) (107)
The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. (2004) (106)
Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. (1994) (105)
Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein‐1 and related chemokines (1995) (103)
IL‐15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium (1997) (103)
T cell receptor beta chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells (1985) (99)
Intestinal Epithelial Cells Control Dendritic Cell Function (2004) (98)
Chemokines: a superfamily of chemotactic cytokines (1996) (98)
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. (1983) (97)
Expression of chemokines and chemokine receptors in human colon cancer. (2009) (97)
Targeting tumor associated macrophages: The new challenge for nanomedicine. (2017) (96)
Distinct Transcriptional Programs Activated by Interleukin-10 with or without Lipopolysaccharide in Dendritic Cells: Induction of the B Cell-Activating Chemokine, CXC Chemokine Ligand 131 (2004) (94)
Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors (1980) (94)
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models (2017) (94)
Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer (2010) (93)
Inflammation as target in cancer therapy. (2017) (89)
Glucocorticoids increase the endocytic activity of human dendritic cells. (1999) (87)
Characteristics of human NK clones: target specificity and phenotype. (1984) (84)
The systemic capillary leak syndrome: appearance of interleukin-2-receptor-positive cells during attacks. (1990) (84)
Differential Effects of Immunosuppressive Drugs on Chemokine Receptor CCR7 in Human Monocyte-Derived Dendritic Cells: Selective Upregulation by Rapamycin (2006) (84)
Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy (1992) (83)
Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells. (1990) (81)
Cytokine Activation of Endothelial Cells: New Molecules for an Old Paradigm (1997) (80)
Tumor-associated macrophages and anti-tumor therapies: complex links (2016) (79)
Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)/CCL20 and MIP-3beta/CCL19. (2001) (77)
Tumor-Associated Macrophages as Incessant Builders and Destroyers of the Cancer Stroma (2011) (77)
Migration of natural killer cells across endothelial cell monolayers. (1993) (76)
Macrophages as tools and targets in cancer therapy (2022) (75)
Targeting tumour-associated macrophages (2007) (71)
Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. (2004) (70)
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient (2016) (70)
The presence of functional mannose receptor on macrophages at the maternal-fetal interface. (2005) (70)
Tumor-associated myeloid cells: diversity and therapeutic targeting (2021) (68)
Autoimmunity and b‐cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cells (1989) (67)
Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy (1989) (67)
Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses (1998) (66)
Inhibition of natural killer activity by human bronchoalveolar macrophages. (1982) (65)
Human Adipose Tissue Macrophages Display Activation of Cancer-related Pathways* (2012) (65)
Tumor-Associated Macrophages and Dendritic Cells as Prototypic Type II Polarized Myeloid Populations (2003) (64)
Tertiary Intratumor Lymphoid Tissue in Colo-Rectal Cancer (2011) (64)
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment (2016) (61)
Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. (2010) (61)
T cell receptor (alpha, beta, gamma) gene rearrangements and expression in normal and leukemic large granular lymphocytes/natural killer cells. (1987) (60)
A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile (2004) (60)
Human monocyte‐derived and CD34+ cell‐derived dendritic cells express functional receptors for platelet activating factor (1997) (59)
Distinct Transcriptional Programs Activated by Interleukin-10 with or without Lipopolysaccharide in Dendritic Cells: Induction of the B Cell-Activating Chemokine, CXC Chemokine Ligand 13. (2004) (58)
Pharmacological modulation of monocytes and macrophages. (2014) (56)
Macrophage control of inflammation: negative pathways of regulation of inflammatory cytokines. (2001) (56)
Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin‐2 activated killer cells and by activated monocytes (1987) (54)
Mesothelial cells induce the motility of human ovarian carcinoma cells (1999) (53)
Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530 (2018) (52)
Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells (1998) (51)
Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients (2016) (51)
In vitro migration of human large granular lymphocytes. (1985) (50)
Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104) (2013) (50)
Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype (2018) (48)
Linking inflammation reactions to cancer: novel targets for therapeutic strategies. (2008) (46)
Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ. (1983) (46)
Secretome analysis of multiple pancreatic cancer cell lines reveals perturbations of key functional networks. (2010) (45)
Soluble stroma‐related biomarkers of pancreatic cancer (2018) (45)
ORIGINAL ARTICLE: Decidual Natural Killer Cell Tuning by Autologous Dendritic Cells (2008) (44)
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis (2017) (44)
Induction of natural-killer-cell migration by monocyte chemotactic protein-1, protein-2 and protein-3 (1994) (43)
Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas. (1981) (42)
Expression and functional activity of CXCR‐4 and CCR‐5 chemokine receptors in human thymocytes (2002) (41)
Lymphokine-activated killer (LAK) and monocyte-mediated cytotoxicity on tumor cell lines resistant to antitumor agents. (1989) (41)
Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. (2003) (41)
Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors. (1986) (40)
Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment (2014) (40)
Effects of granulocyte‐monocyte colony‐stimulating factor (GM‐CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer‐associated macrophages (1995) (39)
Trabectedin: A drug from the sea that strikes tumor-associated macrophages. (2013) (39)
Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery * (2007) (39)
Intraperitoneal administration of corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: Effects on cytotoxicity of tumor‐associated macrophages and NK cells (1981) (38)
Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF). (1985) (38)
IL-10 prevents the generation of dendritic cells from CD14+ blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran. (1997) (38)
Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism (2019) (37)
MAGE, BAGE and GAGE genes experiences in fresh epithelial ovarian carcinomas (1996) (37)
Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways. (2018) (37)
Subsets of human large granular lymphocytes (LGL) exhibit accessory cell functions. (1985) (36)
Fractalkine ( CX 3 CL 1 ) as an amplification circuit of polarized Th 1 responses (2001) (36)
The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination (2016) (34)
Regulation of adhesion and transendothelial migration of natural killer cells. (1996) (34)
Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer (2016) (33)
The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33 (2020) (33)
Identification and genomic organization of a gene coding for a new member of the cell adhesion molecule family mapping to Xq25. (1998) (32)
CD40 activation of BCP-ALL cells generates IL-10-producing, IL-12-defective APCs that induce allogeneic T-cell anergy. (2004) (32)
Tuning of Innate Immunity and Polarized Responses by Decoy Receptors (2003) (32)
H1 variant synthesis in proliferating and quiescent human cells. (1986) (31)
Poly(I:C) stimulation is superior than Imiquimod to induce the antitumoral functional profile of tumor‐conditioned macrophages (2019) (30)
Human glioma tumors express high levels of the chemokine receptor CX3CR1. (2010) (30)
Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells. (1982) (29)
Expression of lineage‐restricted protein tyrosine kinase genes in human natural killer cells (1991) (27)
Myelokathexis associated with multiple congenital malformations: Immunological study on phagocytic cells and lymphocytes (1988) (26)
Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition (2018) (26)
Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis (2013) (25)
Monocytes from Wiskott‐Aldrich patients differentiate in functional mature dendritic cells with a defect in CD83 expression (2001) (25)
Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endothelium. (1992) (25)
Heme-oxygenase-1 Production by Intestinal CX3CR1+ Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis. (2017) (25)
In vitro susceptibility of different human T‐cell subpopulations and resistance of large granular lymphocytes to HTLV‐I infection (1987) (24)
MAGE BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas. (1996) (24)
Soluble intercellular adhesion molecule-1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts. (1994) (24)
Therapeutic Manipulation of Tumor-associated Macrophages: Facts and Hopes from a Clinical and Translational Perspective (2021) (23)
T cell receptor delta gene organization and expression in normal and leukemic natural killer cells. (1989) (22)
Cytokine regulation of tumour-associated macrophages. (1993) (22)
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms (2017) (22)
Production of multiple cytokines by clones of human large granular lymphocytes (2004) (21)
In vitro and in vivo effects of cisplatin on the generation of lymphokine-activated killer cells. (1990) (21)
Association of large granular lymphocyte/natural killer cell proliferative disease and second hematologic malignancy (1988) (21)
Patterns of T cell receptor gamma gene rearrangement and expression in B and T lymphoid malignancies. (1988) (21)
Interleukin‐1 and tumor necrosis factor production in acute non‐lymphoid leukemia (1989) (20)
In Vitro Studies on the Trafficking of Dendritic Cells Through Endothelial Cells and Extra-Cellular Matrix (2000) (20)
Chemokines and chemokine receptors in the regulation of dendritic cell trafficking. (1999) (19)
Targeting of the innate immunity/inflammation as complementary anti-tumor therapies (2011) (19)
Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer (2020) (19)
Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models (2016) (19)
IL-4 inhibits binding and cytotoxicity of NK cells to vascular endothelium. (1994) (19)
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity (2021) (18)
The Role of Chemokines and their Receptors in Tumor Progression and Invasion: Potential New Targets of Biological Therapy (2005) (18)
The chemokine superfamily: crosstalk with the IL-1 system. (1996) (18)
Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1+ Cells (2020) (18)
Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks (2011) (17)
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers. (2008) (17)
Stimulation of cytotoxic and non-cytotoxic functions of natural killer cells by bacterial membrane proteoglycans and ribosomes. (1989) (16)
Chemokines as targets for pharmacological intervention. (1996) (16)
Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability (2000) (16)
PLGA Based Nanoparticles for the Monocyte-Mediated Anti-Tumor Drug Delivery System. (2020) (16)
Tumor-associated macrophages (TAMs) as new target in anticancer therapy (2006) (16)
Association of NK-cell lymphoproliferative disease and nephrotic syndrome. (1990) (16)
Clinical relevance of clonal hematopoiesis in the oldest-old population. (2021) (16)
NATURAL CYTOTOXICITY ON TUMOR CELLS OF HUMAN MONOCYTES AND MACROPHAGES1 (1980) (15)
Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system. (2012) (15)
Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies (2014) (15)
Macrophages and cancer stem cells: a malevolent alliance (2021) (15)
Regulation of the chemokine system at the level of chemokine receptor expression and signaling activity. (2001) (15)
Control of dendritic cell migration by chemokines. (1999) (14)
Cellular and molecular pathways linking inflammation and cancer. Immunobiology (2009) (14)
Lymphokine Production in Ty Lymphoproliferative Disorders (1986) (13)
Induction of cytotoxicity by interleukin‐2 in tγ‐lymphoproliferative disorders (1986) (13)
Non-redundant role of the chemokine receptor CX3CR1 in the anti-inflammatory function of gut macrophages. (2017) (12)
Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors (2020) (12)
Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapy (2021) (11)
Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study. (2013) (11)
Immunohistohemical expression of the chemokine fractalkine and its receptor in the human brain cortex after severe traumatic brain injury and brain hemorrhage. (2013) (11)
Cytokine regulation of monocyte recruitment. (1995) (11)
Inflammatory and Innate Immune Cells in Cancer Microenvironment and Progression (2015) (10)
Commitment of juvenile myelo-monocytic (JMML) leukemic cells to spontaneously differentiate into dendritic cells. (2002) (10)
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma (2021) (10)
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma (2016) (10)
Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy (2018) (10)
New activities for the anti-tumor agent trabectedin: taking two birds with one stone (2013) (9)
IFN-beta partially counteracts inhibition of natural killer activity induced by some antitumor agents. (1998) (9)
Vasodilation in multistep paradigm of leucocyte extravasation (1994) (9)
Cells with stemness features are generated from in vitro transformed human fibroblasts (2018) (9)
Tumor-associated macrophages, multi-tasking cells in the cancer landscape (2015) (9)
Mechanisms of Interleukin‐2-Induced Hydrothoraxy in Mice: Protective Effect of Endotoxin Tolerance and Dexamethasone and Possible Role of Reactive Oxygen Intermediates (1994) (8)
Specificity and phenotype of IL-2 expanded clones of human large granular lymphocytes. (1983) (8)
Regulation of chemokine receptor expression in dendritic cells. (1998) (8)
CHAPTER 15 – Dendritic cells and chemokines (2001) (8)
Differential responsiveness to constitutive versus inflammatory chemokines of immature and mature mouse dendritic cells (1999) (8)
Activated adherent large granular lymphocytes/natural killer (LGL/NK) cells change their migratory behaviour. (1988) (8)
Dendritic Cells Leukocytes: Selective Expression of TLR3 in Toll-Like Receptors (TLR) in Human Differential Expression and Regulation of (2000) (8)
Investigation of chronic lymphocytosis in adults. (1988) (8)
Monocyte–macrophage polarization and recruitment pathways in the tumour microenvironment of B‐cell acute lymphoblastic leukaemia (2021) (7)
Isolation of human monocyte chemotactic proteins and study of their producer and responder cells by immunotests and bioassays. (1997) (7)
Old and new chemokines. Pharmacological regulation of chemokine production and receptor expression: mini-review. (1998) (7)
MODULATION OF NK ACTIVITY BY HUMAN MONONUCLEAR PHAGOCYTES: SUPPRESSIVE ACTIVITY OF BRONCHO-ALVEOLAR MACROPHAGES (1982) (7)
Clinical Relevance of Clonal Hematopoiesis in the Oldest-Old Population (2020) (7)
Original article: Natural killer (NK) and lymphokine activated killer (LAK) cell activity in patients (PTS) treated with favone acetic acid (FAA) (1991) (6)
In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma (2005) (6)
NATURAL KILLER ACTIVITY IN HUMAN OVARIAN TUMORS (1982) (6)
Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines. (2000) (6)
Shaping and tuning of the chemokine system by regulation of receptor expression and signaling: dendritic cells as a paradigm (2000) (6)
Trabectedin (2013) (6)
In vitro and in vivo regulation of chemokine receptors. (2000) (6)
COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC) (2021) (5)
Monocyte-Derived Dendritic Cells Maturation , and Function of Human Affects Differentiation , 3 Vitamin (2000) (5)
DR antigen expression on ovarian carcinoma cells does not correlate with their capacity to elicit an autologous proliferative response (2004) (5)
Trabectedin (2013) (5)
Tumors as a Paradigm for the In Vivo Role of Chemokines in Leukocyte Recruitment (1999) (5)
The good and the bad side of Heme-oxygenase-1 in the gut. (2019) (5)
RAEB IN PATIENT WITH CHRONIC GRANULATED T‐LYMPHOCYTOSIS (1987) (5)
Chemokines and Chemokine Receptors (1999) (5)
Lymphocytes infiltrating ovarian carcinoma: modulation of functional activity by intraperitoneal treatment with biological response modifiers. (1988) (4)
Characterization of human large granular lymphocyte subpopulations: comparison of the phenotype of NK cells and of interleukin 2-dependent progenitors of cytolytic effector cells. (1985) (4)
Program an Anti-Inflammatory Immunosuppressive Monocyte-Derived Dendritic Cells Activates Cross-Linking of the Mannose Receptor on Mantovani (2003) (4)
Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study (2022) (4)
Transendothelial migration and reverse transmigration of in vitro cultured human dendritic cells. (2001) (4)
Optical in vivo imaging detection of preclinical models of gut tumors through the expression of integrin αVβ3 (2018) (4)
Chemotaxis and interaction with vascular or lymphatic endothelium. (2004) (4)
Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer (2016) (4)
The Inflammatory Milieu of Tumors: Cytokines and Chemokines that Affect Tumor Growth and Metastasis (2018) (4)
Mechanisms of natural cell-mediated resistance in human solid tumors. (1986) (4)
Abstract 1284: Lurbinectedin reduces tumor-associated macrophages and the production of inflammatory cytokines, chemokines, and angiogenic factors in preclinical models (2016) (4)
Leukocyte transmigration through vascular endothelium. An in vitro method. (1999) (3)
Role of leukocyte function-associated antigen-1 and very late antigen-4 in the adhesion and transmigration of c-myc-transfected B-lymphoblastoid cell lines across vascular endothelium (1994) (3)
Tumor-Infiltrating Inflammatory Cells as Possible Therapeutic Targets (2012) (3)
Regulatory Dendritic CelllowIL-12 high Differentiating Monocytes and Induce IL-10 Tumor-Derived MUC 1 Mucins Interact with and (2004) (3)
Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment (2022) (3)
Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells (2004) (3)
Corrigendum: Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells (2015) (3)
Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer (2022) (2)
Role of PTX3 in pancreatic cancer (2014) (2)
Microenvironment and Immunology of the Human Pleural Malignant Mesothelioma (2019) (2)
Tumor-Associated Macrophages in Cancer Growth and Progression (2007) (2)
Lymphocytes of a patient with lymphoproliferative disease of large granular lymphocytes express high natural killer, ADCC, and LAK activity. (1990) (2)
Immunological and genotypic analysis of human Tγ-lymphoproliferative disorders (1986) (2)
Molecular links between inflammation and cancer (2015) (2)
Leukocyte Transmigration Through Vascular Endothelium (1999) (2)
Tumor-Associated Macrophages (2014) (2)
Cloned lines of SJL/J spleen cells with cytotoxic reactivity (1983) (2)
Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T-Cells in Cancer Immunotherapy (2020) (2)
The Yin Yang of Cancer Related Inflammation (2011) (2)
Cytokine Regulation of Tumor-Associated Macrophages: Therapeutic Implications (1993) (2)
Cytokine production by clones of human large granular lymphocytes (LGL) (1984) (2)
Killing of tumor cells with pleiotropic drug resistance by OK432-activated effector cells. (1989) (2)
Natural killer (NK) and lymphokine activated killer (LAK) cell activity in patients (PTS) treated with flavone acetic acid (FAA). (1991) (2)
Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells (2005) (2)
Tumor-Associated Myeloid Cells in Cancer Progression (2020) (1)
Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages. (2022) (1)
A17Correlation of metabolic information on 18F-FDG PET with the tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) candidate to upfront surgery (2016) (1)
202: Mediators associated to the inflammatory response in prostate cancer patients undergoing RT: preliminary results (2014) (1)
Endocytic activity of human CD34+ derived dendritic cell (1997) (1)
PS3-05 The chemokine network in the formation of tertiary lymphoid structures in colorectal cancer (2010) (1)
Cytokine Secretion and Noncytotoxic Functions of Human Large Granular Lymphocytes (2019) (1)
Receptors and signaling mechanisms of monocyte chemotactic protein(MCP)-1, MCP-2 and MCP-3 in human monocytes and NK cells (1994) (1)
CLONED LINES OF MOUSE NATURAL KILLER CELLS (1982) (1)
Cytolytic activity against fresh tumor cells of peripheral blood lymphocytes (PBL) and tumor-associated lymphoid cells (TAL) in human ovarian carcinoma: Stimulation by interferon (IF) (1981) (1)
Differentiation and Maturation Glucocorticoids Affect Human Dendritic Cell (1999) (1)
MONOCYTE CHEMOTACTIC PROTEIN-1 IN THE REGULATION OF MONOCYTE RECRUITMENT (1994) (1)
Chemokine and Receptor Expression in Tumor Progression (2007) (1)
Production of the Long Pentraxin PTX3 by Myeloid Dendritic Cells: Linking Cellular and Humoral Innate Immunity (2008) (1)
The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumour Metastatic Dissemination (2017) (1)
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists (2022) (1)
Inflammation and cancer: From bench to bedside? (2007) (1)
W1767 Expression and Function of the Chemokine CX3CL1 and Its Receptor Cx3cr1 in Human Colorectal Cancer (2010) (1)
c‐fos proto‐oncogene expression in human NK/LGL cells: Expression is not constitutive and is associated with functional activation (1988) (1)
P064 Evaluation of mediators associated to the inflammatory response in prostate cancer patients undergoing radiotherapy: Preliminary results (2013) (1)
Optimization of a Luciferase-Expressing Non-Invasive Intrapleural Model of Malignant Mesothelioma in Immunocompetent Mice (2020) (1)
Differential susceptibility of human mononuclear cells to infection with HTLV-I. (1987) (1)
Regulation of chemokine receptors in mononuclear phagocytes versus dendritic cells and in the amplification of Th1 versus Th2 responses. (1998) (1)
Tumor associated glycoprotein -72 modulates phenotype and functional activity of decidual macrophages (2007) (1)
MATURE CD83+ DENDRITIC CELLS ACTIVATE DECIDUAL NK CELLS (2006) (1)
Lymphokine production in T gamma lymphoproliferative disorders. (1986) (1)
Chapter 27 – Tumor-associated Macrophages in Cancer Growth and Progression (2013) (1)
Additional file 2: Figure S2. of Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient (2016) (0)
Inflammation triggered by oncogenic KRasG12V in pancreatic tumor cells (2014) (0)
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Short title: Mesenchymal stem cells migrate to chemokines (2005) (0)
Ovarian Carcinoma Macrophages Associated with Human Chemotactic Protein-1 Receptor CCR 2 in Defective Expression of the Monocyte (1999) (0)
Acknowledgement to our reviewers 2005 (2006) (0)
2 Functions of Diverse Myeloid Cells in the Tumor MicroEnvironment (2017) (0)
Dendritic CD1a+ cells regulate the expansion of CD3+ cells at the maternal fetal interface (2007) (0)
Abstract 2981: Identification of circulating stroma-related biomarkers for pancreatic ductal adenocarcinoma (2017) (0)
Erratum: Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: Induction of the B cell-activating chemokine, CXC chemokine ligand 13 (Journal of Immunology (2004) 172 (7031-7042)) (2004) (0)
The role of pentraxin 3 in pancreatic ductal adenocarcinoma (2014) (0)
Association between metabolite profiles in pancreatic juice and transcriptomic subtypes in pancreatic cancer (2020) (0)
Additional file 1: Figure S1. of Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient (2016) (0)
Tumor associated glycoprotein-72 affects the balance between pro-inflammatory and anti-inflammatory cyto/chemokine production in CD1a+ dendritic cells (2009) (0)
Occurrence of Tertiary Lymphoid Tissue in Pancreatic Adenocarcinoma (2013) (0)
Induction of cytotoxicity by interleukin-2 in T gamma-lymphoproliferative disorders. (1986) (0)
CULTURE OF NK CELLS: SPECIFICITY, PHENOTYPES, FUNCTIONS AND COMPARISON WITH ACTIVATED T CELLS (1985) (0)
Characterization of the Adhesion Structures of Human Adherent LGL/NK Cells Activated by IL-21 (1990) (0)
to pancreatic islets functionally active chemokine receptors capable of promoting migration Bone marrow mesenchymal stem cells express a restricted set of (2013) (0)
Macrophages and cancer stem cells: a malevolent alliance (2021) (0)
IL-4 and IL-13 in Human Monocytes Induction of Functional IL-8 Receptors by (2013) (0)
Cells with stemness features are generated from in vitro transformed human fibroblasts (2018) (0)
Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism (2019) (0)
Tumor-associated macrophages and anti-tumor therapies: complex links (2016) (0)
HTLV-I infection of T lymphocytes separated from human cord and peripheral blood by fractionation (1985) (0)
M2036 Early Fractalkine Receptor (CX3CR1) Switch-On in Pancreatic Ductal Adenocarcinoma Is Associated with Local Neural Invasion (2008) (0)
Tumor-associated macrophages: functional diversity, clinical significance, and open questions (2013) (0)
Running Title: T cell anergy induced by CD40L-activated BCP ALL cells. (2013) (0)
Anti-inflammatory properties of decidual NK cells are mediated by CD1a+ cells (2007) (0)
Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques (1996) (0)
Purification and characterization of the motogenic properties of Migration Stimulating Factor, a genetically truncated onco-fetal isoform of human fibronectin 1 (2017) (0)
The presence of functional mannose receptor at the materno-fetal interface (2004) (0)
Chemokines in leukocyte recruitment: Cellular targets and signal transduction (1996) (0)
Decidual CD1a+ cells are able to shape the percentage and functions of CD56+bright and CD3+ cells at the maternal-fetal interface (2007) (0)
Macrophage polarization in pathology (2015) (0)
T-cell receptor gene rearrangements and expression in normal human large granular lymphocytes (LGL) and their pathological expansions (1987) (0)
' s report Title : Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors Version : 1 Date : 7 December 2011 (0)
Cytotoxicity on tumor cells of human macrophages: functional status of tumor-associated effector cells. (1982) (0)
Large granular lymphocyte (LGL) subsets with ability to produce B-cell growth factor (1984) (0)
869 A Novel Sierological Inflammatory Score As Possible Prognostic Marker in Colorectal Cancer (2015) (0)
Tumor-associated Macrophages: Cytokine Regulation and Therapeutic Implications (1993) (0)
A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma (mPA) (2013) (0)
OC3.01.3 EARLY FRACTALKINE RECEPTOR (CX3CR1) EXPRESSION IN PANCREATIC DUCTAL ADENOCARCINOMA AND LOCAL NEURAL INVASION (2008) (0)
Functions of Diverse Myeloid Cells in the Tumor Micro-Environment (2012) (0)
Author response for "Inhibition of Tumor‐Associated Macrophages by trabectedin improves the anti‐tumor adaptive immunity in response to anti‐PD‐1 therapy" (2021) (0)
Abstract 4892: Pentraxin 3: A stromal derived diagnostic biomarker for pancreatic ductal adenocarcinoma (2019) (0)
Metabolomics analysis of pancreatic juice indicates an alteration in glucose metabolism in pancreatic ductal adenocarcinoma patients (2018) (0)
Cytotoxic lymphocytes from ovarian cancer patients reactive against autologous tumor (1985) (0)
FAM 49 B , a novel regulator of mitochondrial function and integrity that 1 suppresses tumour metastasis 2 3 (0)
Chemotaxis of in vitro cultured human dendritic cells. (2001) (0)
How CX3CR1 + Macrophages Regulate Gut Homeostasis (2017) (0)
Production of multiple cytokine by subsets of human large granular lymphocytes (LGL) (1984) (0)
EP07.01-004 Long Survivor Epithelioid Pleural Mesotheliomas Are Characterized by Tertiary Lymphoid Structures: An Update to the MATCH Study (2022) (0)
IL-10 inhibits dendritic cell differentiation from circulating blood precursors and favours their differentiation into macrophages (1996) (0)
Sa1371 Pentraxin3 Is a Stromal Biomarker in Pancreatic Ductal Adenocarcinoma (2014) (0)
H43ATREUS Trial: A Phase II Study On The Activity Of Trabectedin In Pretreated Epithelioid Or Biphasic/Sarcomatoid Malignant Pleural Mesothelioma (MPM) (2015) (0)
Tumor associated glycoprotein-72 and mucin I show distinct impact on decidual dendritic cells functions (2009) (0)
Induction of a proinflammatory program in normal human thyrocytes by the RET (cid:1) PTC1 oncogene (2005) (0)
Corrigendum to ‘COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)’ [ESMO Open Volume 6, Issue 3, June 2021, 100165] (2021) (0)
In Vitro Methods to Evaluate Macrophage Polarization and Function in Cancer. (2023) (0)
Tumour-derived high molecular weight M-CSF induces monocyte differentiation into M2- polarized macrophages (2008) (0)
FUNCTIONAL STATUS OF TUMOR-ASSOCIATED EFFECTOR CELLS (1982) (0)
Early Switch-on of the Chemotactic Fractalkine Axis and Its Dynamic Variation in Pancreatic Cancer Invasion and Progression (2011) (0)
Phenotypic and functional characteristic of the first trimester pregnancy decidual CD1a+ dendritic cells (2007) (0)
Abstract A56: The role of Pentraxin 3 (PTX3) in pancreatic ductal adenocarcinoma (2015) (0)
Biological Significance and Therapeutic Potential of Tumor-Associated Leukocytes (1993) (0)
Referee Acknowledgement for 2013 (2014) (0)
Effect of intra peritoneal corynebacterium parvum propionibacterium acnes on the tumoricidal activity of tumor associated macrophages and tumor associated lymphocytes from ascitic ovarian tumors (1982) (0)
Molecules Involved in the Recruitment and Regulation of Tumor-Associated Macrophages (1998) (0)
Tumour-derived soluble factors induce differentiation of monocytes into M2- polarized macrophages (2007) (0)
Chemokines: Attraction of dendritic cells and role in tumor immunobiology (1998) (0)
Referee Acknowledgement for 2012 (2013) (0)
Natural killer and dendritic cell interaction at the maternal-fetal interface (2007) (0)
Tumor associated glycoprotein-72 inhibits the maturation and induces anti-inflammatory properties of decidual CD1a+ dendritic cells (2007) (0)
B cells modulate the antitumor immune response according to their spatial distribution within the microenvironment of pancreatic adenocarcinoma (2016) (0)
Regulatory Activity T Lymphocytes with + Function in CD4 Chemokine Receptor Expression and (2000) (0)
Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting (2023) (0)
Regulation of Inflammatory Cytokine Receptor Expression by Pro- and Anti-Inflammatory Molecules (1998) (0)
Effect of i.p. C. Parvum on the tumoricidal activity of tumor-associated macrophages and tumor-associated lymphocytes from ascitic ovarian tumors (1982) (0)
Tumor associated glycoprotein-72 (TAG-72) orientates the immune response via CD1a+ dendritic cells (2008) (0)
Impairement of human NK activity by cyclosporin A (1980) (0)
Lymphokines and monokines (1985) (0)
Gene Rearrangements and Expression in Normal and Leukemic Large Granular Lymphocytes / Natural Killer Cells (2005) (0)
malignant tissues possible mechanism contributing to blood clotting activation within Generation of procoagulant activity by mononuclear phagocytes: a (2011) (0)
Author response for "Poly(I:C) stimulation is superior than Imiquimod to induce the anti-tumoral functional profile of tumor-conditioned macrophages" (2019) (0)
Expression and natural ligands for the mannose receptor at the materno-fetal interface (2010) (0)
In Vivo Analysis of Tumor-Associated Macrophages in the Tumor Microenvironment. (2023) (0)
Expression of the T Cell Receptor δ Gene in Normal and Leukemic Natural Killer Cells1 (1990) (0)
A randomized clinical trial to compare the efficacy of continuous local anesthetic wound infusion with thoracic epidural analgesia in post-operative pain control after pancreatic surgery (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paola Allavena?

Paola Allavena is affiliated with the following schools:

Paola Allavena's Academic­Influence.com Rankings

Why Is Paola Allavena Influential?

Paola Allavena's Published Works

Published Works

What Schools Are Affiliated With Paola Allavena?

Paola Allavena's AcademicInfluence.com Rankings